Skip to main content
SpringerLink
Log in

Efficacy and safety of a single 400 mg oral dose of cefixime in the treatment of uncomplicated gonorrhea

  • New Antimicrobial Agents
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Neu, H. C., Chin, N., Labthavikul, P. Comparative in vitro activity and β-lactamase stability of FR 17027, a new orally active cephalosporin. Antimicrobial Agents and Chemotherapy 1984, 26: 174–180.

    PubMed  Google Scholar 

  2. Bowie, W. R., Shaw, C. E., Chan, D. G. W., Boyd, J., Black, W. A. In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284, 635; FK 027) against selected genital pathogens. Antimicrobial Agents and Chemotherapy 1986, 30: 590–593.

    PubMed  Google Scholar 

  3. Saito, I.: Fundamental and clinical studies of FK 027 in gonorrhea: In: Moellering, R. C., Shimada, K., (ed.): A Review of New Oral Cephems, Proceedings of a Workshop Held at the 14th International Congress of Chemotherapy, Kyoto, 1985, p. 55–58.

  4. Fuchs, P. C., Jones, R. N., Barry, A. L., Thornsberry, C., Ayers, L. W., Gavan, T. L., Gerlach, E. H. In vitro evaluation of cefixime (FK 027, FR 17027, CL 284 635): spectrum against recent clinical isolates, comparative antimicrobial activity, β-lactamase stability, and preliminary susceptibility testing criteria. Diagnostic Microbiology and Infectious Diseases 1986, 5: 151–162.

    Article  Google Scholar 

  5. Grimm, H. Antibakterielle in-vitro-Wirkung neuer oraler Cephalosporine und Empfindlichkeitsprüfung von Cefixim im Agardiffusionstest. Fortschritte der antimikrobiellen und antineoplastischen Chemotherapie 1987, 6–8: 1201–1211.

    Google Scholar 

  6. Treatment of drug-resistant gonorrhea. American Society for Microbiology News 1987, 53: 197.

    Google Scholar 

  7. Brittain, D. C., Scully, B. E., Hirose, T., Neu, H. C. The pharmacokinetic and bactericidal characteristics of oral cefixime. Clinical Pharmacology and Therapeutics 1984, 38: 590–594.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Health Officer of Hamburg City, Alter Steinweg 4, 2000, Hamburg, FRG

    A. Kuhlwein

  2. Department of Medical Research, E. Merck, Frankfurter Straße 250, 6100, Darmstadt, FRG

    B. A. Nies

Authors
  1. A. Kuhlwein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. A. Nies
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuhlwein, A., Nies, B.A. Efficacy and safety of a single 400 mg oral dose of cefixime in the treatment of uncomplicated gonorrhea. Eur. J. Clin. Microbiol. Infect. Dis. 8, 261–262 (1989). https://doi.org/10.1007/BF01965274

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01965274

Keywords

Search

Navigation